New Zealand markets close in 40 minutes

Vir Biotechnology, Inc. (VIR)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
27.07-2.38 (-8.08%)
At close: 04:00PM EST
27.10 +0.03 (+0.11%)
After hours: 07:17PM EST
Full screen
Trade prices are not sourced from all markets
Previous close29.45
Bid27.02 x 1000
Ask27.14 x 900
Day's range27.04 - 29.00
52-week range18.05 - 34.63
Avg. volume795,605
Market cap3.603B
Beta (5Y monthly)0.19
PE ratio (TTM)3.25
EPS (TTM)8.32
Earnings date22 Feb 2023 - 27 Feb 2023
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est54.43
  • GlobeNewswire

    Vir Biotechnology Announces Retirement of CEO George Scangos, Ph.D.; Appoints Marianne De Backer, MSc, Ph.D., MBA, as Successor

    – Dr. De Backer to assume CEO role on April 3, 2023 – – Upon his retirement as CEO, Dr. Scangos will transition to an advisory role through June 2, 2023 and will continue providing strategic counsel to Vir as a member of the Board of Directors – SAN FRANCISCO, Jan. 25, 2023 (GLOBE NEWSWIRE) -- Vir Biotechnology, Inc. (Nasdaq: VIR) today announced that George Scangos, Ph.D., will retire from his position as Chief Executive Officer (CEO), effective April 3, 2023. The Company’s Board of Directors h

  • Zacks

    Vir Biotechnology, Inc. (VIR) Moves to Strong Buy: Rationale Behind the Upgrade

    Vir Biotechnology, Inc. (VIR) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

  • Motley Fool

    2 Stocks That Could Turn $100 Into $1,000 by 2028

    Doing so requires a substantial compound annual growth rate (CAGR) exceeding 58%. You're not likely to see such a rate among value stocks, which for all their consistency rarely grow at that pace. Two companies where I see that kind of progress over the next five years are Vir Biotechnology (NASDAQ: VIR) and Albemarle (NYSE: ALB).